Patrick Hsu (born June 25, 1993) is an American bioengineer and molecular biologist specializing in CRISPR, genome engineering, synthetic biology, and gene therapy.

He is an assistant professor of bioengineering at the University of California, Berkeley and a co-founder and director of the Arc Institute, a research organization focused on accelerating biomedical discovery.

He then completed his Ph.D. at Harvard University under the mentorship of Feng Zhang at the Broad Institute, where he contributed to early developments in CRISPR-based gene-editing technologies.

[3] He later joined the faculty at the University of California, Berkeley, where his lab focuses on engineering CRISPR-based technologies for gene editing and therapeutic applications.

[5] His work has been recognized for integrating artificial intelligence into genome design, leading to the development of Evo 2, one of the most powerful AI models in biology.